Immunotherapy approach offers hope for long-term HIV control without daily medication

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
Medscape

Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
Clinical Trials Arena on MSN

Gilead to present data on potential first weekly oral treatment for HIV

The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
EurekAlert!

The RESTART trial: a drug to block a toxic HIV molecule

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
PBS

How a new twice-yearly drug is prompting hopes of curbing HIV cases

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But deep cuts to health initiatives could hinder the rollout. Lenacapavir not only ...
KHQ

FDA approves 100% effective HIV treatment years after Spokane clinical trials

SPOKANE, Wash. – The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the approval, Dr. Rachel Safran was part of an original ...

Findings on a toxic HIV molecule pave way for clinical drug trial

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH ... a ...
The American Journal of Managed Care

High Burdens of Drug Resistance Found in Children With HIV

Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with HIV. The rate of transmission of HIV from a mother to her child without ...
Wall Street Journal

FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV

Health Secretary Robert F. Kennedy Jr. testified in May before Congressional lawmakers on President Trump’s budget, where protesters, including Ben & Jerry’s co-founder Ben Cohen, disrupted his ...

Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.
WebMD

FDA Approves First Twice-Yearly Shot to Prevent HIV

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...
PBS

EU regulator approves injectable HIV drug that experts say could help stop transmission

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a ...